Zimmer Biomet Holdings, Inc at Goldman Sachs Healthcare Conference Transcript
Good morning, everyone. I'll go ahead and get started here with the next session. I'm very pleased to welcome the management team from Zimmer Ivan Tornos Chairman and Chief Executive Officer; and Paul Stellato, Interim Chief Financial Officer. I obviously have a bunch of questions, but happy to open it up to others. Should you have questions, we'll just get you a mic for those participating on the webcast so they can hear.
Questions & Answers
Maybe I'll just kind of start with a very dynamic year for Zimmer Biomet with the sales force transition. And one of the things that you clarified recently was this investor dialogue ground, 1099 versus FTE and dedicated and non-dedicated. Maybe just sort of set the registry like what are you actually doing? Why are we doing it? And where are you in that
Well, first of all, thank you for -- so the go-to-market changes in the US Maybe let me just
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

